US Senate Panel OKs 12-Year Biologic Drug Exclusivity - Wall Street Journal
Tags: us, senate, panel, oks, year, biologic, drug, exclusivity, , wall, street, journal
US Senate Panel OKs 12-Year Biologic Drug ExclusivityWall Street JournalWASHINGTON (Dow Jones)--The Senate Health, Education, Labor and Pensions Committee approved an amendment late Monday that would protect makers of biologic drugs from competition from generic drug manufacturers for 12 years. ...When Should Biotech Drugs Face Generic Competition?Wall Street Journal BlogsTempers rise as biosimilar debate reaches a boilFierceBiotechUS Senate panel backs 12-year biotech drug shelterInteractive InvestorDaily Mail - Charlestonall 171 news articles »
What is Health Bubble?
Health Bubble is a health information site that depends on its users
to curate the best resource directory on the web.
